AmeriSourceBergen building three facilities to support US distribution

By Dan Stanton

- Last updated on GMT

AmeriSourceBergen building three facilities to support US distribution

Related tags Remainder Pharmacology Us

AmeriSourceBergen will increase its US pharmaceutical distribution network to 28 sites through the construction of three new facilities.

According to company spokesperson Gabe Weissman, AmeriSourceBergen’s distribution network handles nearly 35% of all the pharmaceuticals sold and distributed throughout the US and plans to build three new sites to help support this.

The company “currently operates 25 distribution centres in the US,”​ he told Outsourcing-Pharma.com, and efforts such as this to expand its distribution network helps to “increase efficiency and drive innovation in pharmaceutical distribution and the delivery of healthcare.”

The new centres will be located in Olive Branch, Mississippi; Shakopee, Minnesota; and Newburgh, New York. Construction set to begin early this summer and is expected it will be up to two years before they are operational.

The expansion comes as part of a continued ramp-up of operations both in the US and globally. Over $1bn (€900,000m) has been invested across its network in the past decade, with a site in Columbus being the last centre to have benefitted.

“We have more than doubled the volume going through the facility during the March quarter, and we will continue to add additional manufacturers to its programmess over the remainder of the fiscal year,”​ CEO Steven Collis told investors in April (transcript here​).

Such a large distribution network requires controls to guarantee GDP compliance for both the security of the supply chain and the environmental conditions for the storing and distribution of pharmaceuticals. However, Weissman did not respond to how AmeriSourceBergen ensures this when asked.

Related news

Show more

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Follow us

Products

View more

Webinars